Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Change in Inventory (2024 - 2025)

Insight Molecular Diagnostics (IMDX) has disclosed Change in Inventory for 2 consecutive years, with -$25000.0 as the latest value for Q4 2025.

  • Quarterly Change in Inventory fell 114.04% to -$25000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $36000.0 through Dec 2025, down 91.22% year-over-year, with the annual reading at $36000.0 for FY2025, 91.22% down from the prior year.
  • Change in Inventory hit -$25000.0 in Q4 2025 for Insight Molecular Diagnostics, up from -$222000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $234000.0 in Q2 2025 to a low of -$222000.0 in Q3 2025.